UnitedHealth Group Incorporated $UNH Stock: Allen Investment Management LLC Reduces Position

Key Points

• Allen Investment Management cut its UnitedHealth stake by 5.4% in Q3, selling 47,693 shares and retaining 828,566 shares valued at about $304.2 million.
• UnitedHealth reported quarterly EPS of $4.69, beating the $4.14 consensus, and revenue of $112.72 billion, above estimates; revenue nevertheless slipped 0.4% year over year.
• The company declared a quarterly dividend of $2.32 per share, or $9.28 annualized. Analysts’ consensus rating was “Moderate Buy,” with an average price target of $463.93.

Allen Investment Management LLC trimmed its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 5.4% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 828,566 shares of the healthcare conglomerate's stock after selling 47,693 shares during the period. UnitedHealth Group comprises approximately 3.4% of Allen Investment Management LLC's holdings, making the stock its 7th largest holding. Allen Investment Management LLC owned about 0.09% of UnitedHealth Group worth $304,150,000 as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in the stock. BlackRock Inc. raised its holdings in UnitedHealth Group by 4.6% in the second quarter. BlackRock Inc. now owns 76,863,061 shares of the healthcare conglomerate's stock valued at $31,946,594,000 after acquiring an additional 3,395,530 shares in the last quarter. State Street Corp boosted its stake in UnitedHealth Group by 0.7% during the 2nd quarter. State Street Corp now owns 45,633,267 shares of the healthcare conglomerate's stock valued at $18,966,555,000 after acquiring an additional 301,081 shares during the last quarter. Bank of New York Mellon Corp grew its holdings in UnitedHealth Group by 6.1% during the 2nd quarter. Bank of New York Mellon Corp now owns 10,704,994 shares of the healthcare conglomerate's stock worth $4,449,317,000 after acquiring an additional 616,723 shares in the last quarter. Wellington Management Group LLP increased its position in shares of UnitedHealth Group by 5.8% in the 2nd quarter. Wellington Management Group LLP now owns 10,675,175 shares of the healthcare conglomerate's stock worth $4,436,923,000 after purchasing an additional 583,536 shares during the last quarter. Finally, Corient Private Wealth LP increased its position in shares of UnitedHealth Group by 1,443.7% in the 2nd quarter. Corient Private Wealth LP now owns 8,447,224 shares of the healthcare conglomerate's stock worth $3,510,920,000 after purchasing an additional 7,900,011 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company's stock.

Insider Buying and Selling at UnitedHealth Group

In related news, CEO Patrick Conway sold 1,169 shares of the firm's stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $390.00, for a total value of $455,910.00. Following the sale, the chief executive officer owned 15,328 shares of the company's stock, valued at approximately $5,977,920. This trade represents a 7.09% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 0.19% of the company's stock.

UnitedHealth Group Trading Down 0.4%

UnitedHealth Group stock opened at $394.14 on Friday. UnitedHealth Group Incorporated has a 1 year low of $255.96 and a 1 year high of $461.62. The firm's 50-day moving average is $390.62 and its 200-day moving average is $364.03. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.78 and a current ratio of 0.74. The company has a market cap of $353.16 billion, a P/E ratio of 22.51, a PEG ratio of 1.43 and a beta of 0.51.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings data on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share for the quarter, topping the consensus estimate of $4.14 by $0.55. UnitedHealth Group had a net margin of 3.53% and a return on equity of 17.95%. The firm had revenue of $112.72 billion for the quarter, compared to analyst estimates of $111.31 billion. During the same quarter in the prior year, the business earned $2.59 earnings per share. UnitedHealth Group's quarterly revenue was down .4% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. On average, equities analysts expect that UnitedHealth Group Incorporated will post 20.61 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 15th. Stockholders of record on Monday, December 7th will be given a dividend of $2.32 per share. This represents a $9.28 dividend on an annualized basis and a dividend yield of 2.4%. The ex-dividend date is Monday, December 7th. UnitedHealth Group's dividend payout ratio is presently 53.00%.

Trending Headlines about UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: ETFs purchased $56.4 million of UNH shares on Nov. 4, a potentially supportive demand signal. ETFs Are Buying UnitedHealth (UNH) on Nov. 4
• Positive Sentiment: UnitedHealth’s Q3 adjusted EPS of $4.69 topped analyst expectations, and a recent earnings analysis said the results bolstered confidence in a margin recovery. UnitedHealth (UNH) Q3 Earnings Lift Confidence In Margin Recovery
• Positive Sentiment: A Zacks article characterized Wall Street analysts’ view of UNH as a Buy, offering a favorable sentiment signal, though the article summary did not cite a specific new rating change. Wall Street Analysts See UnitedHealth (UNH) as a Buy: Should You Invest?
• Positive Sentiment: The company declared a quarterly dividend of $2.32 per share, equivalent to $9.28 annually and a reported yield of 2.3%. UnitedHealth Group Declares Quarterly Dividend Of $2.32 Per Share
• Negative Sentiment: Utilization and policy concerns remain an overhang for the company, highlighting uncertainty around medical costs and the regulatory environment. Utilization and Policy Concerns Weigh on UnitedHealth Group Incorporated (UNH)
• Negative Sentiment: Renewed calls for a regulatory review of UnitedHealth’s business scale, alongside warnings that AI could disrupt large healthcare companies, add longer-term risk concerns. UnitedHealth Group (UNH) Draws Breakup Pressure As AI Threat Enters The Story

Analysts Set New Price Targets

Several equities analysts have recently commented on UNH shares. Sanford C. Bernstein reduced their price target on shares of UnitedHealth Group from $512.00 to $500.00 and set an "outperform" rating on the stock in a research report on Wednesday, October 14th. Deutsche Bank Aktiengesellschaft boosted their price objective on UnitedHealth Group from $370.00 to $467.00 and gave the company a "hold" rating in a report on Friday, July 17th. Bank of America restated a "buy" rating and set a $450.00 price objective on shares of UnitedHealth Group in a research note on Monday, July 20th. Wells Fargo & Company cut their price objective on UnitedHealth Group from $526.00 to $487.00 and set an "overweight" rating on the stock in a research note on Tuesday, October 27th. Finally, Jefferies Financial Group lifted their target price on UnitedHealth Group from $401.00 to $490.00 and gave the stock a "buy" rating in a research report on Friday, July 17th. Twenty research analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company. According to MarketBeat.com, UnitedHealth Group currently has a consensus rating of "Moderate Buy" and an average target price of $463.93.

UnitedHealth Group Company Profile

UnitedHealth Group is a diversified health care company that provides health benefits and health services through two main businesses: UnitedHealthcare and Optum. UnitedHealthcare offers health insurance and related benefit plans to individuals, employers and government programs, including Medicare and Medicaid.

Optum provides services across the health care system, including care delivery, pharmacy services, pharmacy benefit management, health technology and data analytics. Its businesses serve consumers, health care providers, employers, health plans and government organizations.

Founded in 1977 as United HealthCare Corporation, the company is headquartered in Minnetonka, Minnesota.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.